ZA201800067B - Drospirenone-based contraceptive for a female patient affected with excess weight - Google Patents

Drospirenone-based contraceptive for a female patient affected with excess weight

Info

Publication number
ZA201800067B
ZA201800067B ZA2018/00067A ZA201800067A ZA201800067B ZA 201800067 B ZA201800067 B ZA 201800067B ZA 2018/00067 A ZA2018/00067 A ZA 2018/00067A ZA 201800067 A ZA201800067 A ZA 201800067A ZA 201800067 B ZA201800067 B ZA 201800067B
Authority
ZA
South Africa
Prior art keywords
drospirenone
female patient
excess weight
patient affected
based contraceptive
Prior art date
Application number
ZA2018/00067A
Other languages
English (en)
Inventor
Drouin Dominique
Boyer-Joubert Cécile
Perrin Philippe
Original Assignee
Laboratorios Leon Farma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=56178376&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201800067(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from CN201510348953.1A external-priority patent/CN106265694A/zh
Priority claimed from EP15305965.4A external-priority patent/EP3108889A1/en
Application filed by Laboratorios Leon Farma Sa filed Critical Laboratorios Leon Farma Sa
Publication of ZA201800067B publication Critical patent/ZA201800067B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA2018/00067A 2015-06-23 2018-01-04 Drospirenone-based contraceptive for a female patient affected with excess weight ZA201800067B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201510348953.1A CN106265694A (zh) 2015-06-23 2015-06-23 用于过重女性患者的基于屈螺酮的避孕药
EP15305965.4A EP3108889A1 (en) 2015-06-23 2015-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight
PCT/EP2016/064574 WO2016207298A1 (en) 2015-06-23 2016-06-23 Drospirenone-based contraceptive for a female patient affected with excess weight

Publications (1)

Publication Number Publication Date
ZA201800067B true ZA201800067B (en) 2019-07-31

Family

ID=56178376

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2018/00067A ZA201800067B (en) 2015-06-23 2018-01-04 Drospirenone-based contraceptive for a female patient affected with excess weight

Country Status (26)

Country Link
EP (1) EP3313408B1 (OSRAM)
JP (1) JP6827962B2 (OSRAM)
KR (1) KR102217942B1 (OSRAM)
CN (2) CN108025014B (OSRAM)
AU (1) AU2016282863B2 (OSRAM)
BR (1) BR112017028048A2 (OSRAM)
CA (1) CA2989975C (OSRAM)
DK (1) DK3313408T3 (OSRAM)
EA (1) EA036497B1 (OSRAM)
ES (1) ES2970532T3 (OSRAM)
FI (1) FI3313408T3 (OSRAM)
HR (1) HRP20240121T8 (OSRAM)
HU (1) HUE065350T2 (OSRAM)
LT (1) LT3313408T (OSRAM)
MX (1) MX389310B (OSRAM)
MY (1) MY187233A (OSRAM)
NI (1) NI201700173A (OSRAM)
PH (1) PH12017502379A1 (OSRAM)
PL (1) PL3313408T3 (OSRAM)
RS (1) RS65196B1 (OSRAM)
SI (1) SI3313408T1 (OSRAM)
SM (1) SMT202400062T1 (OSRAM)
SV (1) SV2017005602A (OSRAM)
UA (1) UA122873C2 (OSRAM)
WO (1) WO2016207298A1 (OSRAM)
ZA (1) ZA201800067B (OSRAM)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2383279A1 (en) 2011-07-19 2011-11-02 Pantarhei Bioscience B.V. Process for the preparation of estetrol
MY195019A (en) 2015-06-18 2023-01-03 Estetra Sprl Orodispersible dosage unit containing an estetrol component
MD3310346T2 (ro) 2015-06-18 2021-06-30 Estetra Sprl Comprimată orodispersabilă ce conține estetrol
JP6866560B2 (ja) 2015-06-18 2021-04-28 エステトラ ソシエテ プリーヴ ア レスポンサビリテ リミテ エステトロール成分を含有する口腔内崩壊性投与単位
HUE054589T2 (hu) 2015-06-18 2021-09-28 Estetra Sprl Szájban diszpergálódó esztetrol tartalmú tabletta
MX389310B (es) 2015-06-23 2025-03-20 Laboratorios Leon Farma Sa Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.
KR102712911B1 (ko) 2016-08-05 2024-10-04 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 월경통 및 생리통의 관리방법
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI893101B (zh) 2020-04-16 2025-08-11 比利時商埃斯特拉有限責任公司 具有降低之副作用之避孕組成物
EP4134082A1 (en) 2021-08-12 2023-02-15 Chemo Research, S.L. Method for treating endometriosis and providing effective contraception

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2652761C2 (de) 1976-11-16 1985-11-21 Schering AG, 1000 Berlin und 4709 Bergkamen 15,16-Methylen-Spirolactone, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19525017A1 (de) * 1995-06-28 1997-01-02 Schering Ag Pharmazeutisches Kombinatonspräparat, Kit und Methode zur hormonalen Kontrazeption
DE19633685C1 (de) 1996-08-12 1997-10-09 Schering Ag Verfahren zur Herstellung von Drospirenon (6beta,7beta;15 beta,16beta-Dimethyl-en-3-oxo-17alpha-pregn-4-en-21,17-carbolacton, DRSP) sowie 7alpha-(3-Hydroxy-1-propyl)-6beta,7beta;15beta, 16beta-dimethylen-5beta-androstan-3beta,5,17beta-triol (ZK 92836) und 6beta,7beta;15beta,16beta-dimethylen-5beta-hydroxy-3-oxo-17alpha-androstan-21,17-carbolacton (90965) als Zwischenprodukte des Verfahrens
WO2004041288A1 (en) * 2002-11-05 2004-05-21 Schering Aktiengesellschaft Hormone replacement therapy with drospirenone
CN107875388A (zh) * 2004-04-30 2018-04-06 拜耳知识产权有限责任公司 对延长的激素避孕方案中突破性出血的控制
MY151322A (en) * 2004-04-30 2014-05-15 Bayer Ip Gmbh Management of breakthrough bleeding in extended hormonal contraceptive regimens
EP1773344A1 (en) * 2004-07-07 2007-04-18 Wyeth a Corporation of the State of Delaware Cyclic progestin regimens and kits
ITMI20042338A1 (it) 2004-12-06 2005-03-06 Ind Chimica Srl Processo per la preparazione di drospirenone
ATE403668T1 (de) 2005-07-21 2008-08-15 Bayer Schering Pharma Ag Verfahren zur herstellung von 3-oxo-pregn-4-en-21,17-carbolactonen durch die metallfreie oxidation von 17-(3-hydroxypropyl)-3,17- dihydroxyandrostanen
MX2009010763A (es) * 2007-04-05 2009-10-28 Bayer Schering Pharma Ag NUEVO REGIMEN DE DROSPIRENONA/17ß-ESTRADIOL, PRODUCTO FARMACEUTICO COMBINADO Y CONJUNTO DE ELEMENTOS (KIT) PARA SU APLICACION.
EP2548881B1 (en) * 2010-03-16 2014-12-17 Taizhou Taifa Pharmaceuticals Co., Ltd Preparation method of drospirenone
RU2422824C1 (ru) * 2010-05-07 2011-06-27 Федеральное Государственное Учреждение Ростовский научно-исследовательский институт акушерства и педиатрии Федерального агентства по высокотехнологичной медицинской помощи Способ выбора тактики лечения нарушений менструального цикла у девочек-подростков с избыточной массой тела
US9375437B2 (en) * 2010-06-18 2016-06-28 Lipocine Inc. Progesterone containing oral dosage forms and kits
AR081670A1 (es) * 2010-06-29 2012-10-10 Leon Farma Sa Lab Composicion farmaceutica que comprende drospirenona y kit anticonceptivo
CN103372015A (zh) * 2012-04-19 2013-10-30 国家人口计生委科学技术研究所 包含屈螺酮或屈螺酮和雌激素的阴道环制剂
RU2527357C1 (ru) * 2013-08-02 2014-08-27 Государственное бюджетное образовательное Учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет имени А.И. Евдокимова" Министерства здравоохранения Российской Федерации (МГМСУ имени А.И. Евдокимова" Минздрава России) Способ персонифицированной профилактики эстрогензависимых заболеваний у здоровых женщин и женщин с факторами сердечно-сосудистого риска в возрасте 45-60 лет
MX389310B (es) 2015-06-23 2025-03-20 Laboratorios Leon Farma Sa Anticonceptivos a base de drospirenona para paciente femenina afectada con exceso de peso.

Also Published As

Publication number Publication date
SV2017005602A (es) 2018-08-14
KR102217942B1 (ko) 2021-02-19
WO2016207298A1 (en) 2016-12-29
CN113750108B (zh) 2025-08-19
EA201792595A1 (ru) 2018-06-29
CN108025014A (zh) 2018-05-11
EP3313408B1 (en) 2023-12-06
ES2970532T3 (es) 2024-05-29
UA122873C2 (uk) 2021-01-13
HUE065350T2 (hu) 2024-05-28
HRP20240121T1 (hr) 2024-04-12
DK3313408T3 (da) 2024-01-29
PH12017502379A1 (en) 2018-06-25
AU2016282863B2 (en) 2021-05-27
AU2016282863A1 (en) 2018-02-08
SI3313408T1 (sl) 2024-04-30
MX389310B (es) 2025-03-20
BR112017028048A2 (pt) 2018-09-04
NI201700173A (es) 2018-04-02
JP2018527305A (ja) 2018-09-20
SMT202400062T1 (it) 2024-03-13
CN108025014B (zh) 2021-10-22
MX2017016801A (es) 2018-05-11
JP6827962B2 (ja) 2021-02-10
CN113750108A (zh) 2021-12-07
EP3313408A1 (en) 2018-05-02
FI3313408T3 (fi) 2024-01-25
HRP20240121T8 (hr) 2024-05-10
PL3313408T3 (pl) 2024-04-15
LT3313408T (lt) 2024-03-12
NZ739195A (en) 2024-04-26
RS65196B1 (sr) 2024-03-29
CA2989975A1 (en) 2016-12-29
EA036497B1 (ru) 2020-11-17
CA2989975C (en) 2021-10-12
HK1255216A1 (zh) 2019-08-09
KR20180019173A (ko) 2018-02-23
MY187233A (en) 2021-09-13

Similar Documents

Publication Publication Date Title
IL281584B (en) Expandable gastric retention dosage form
ZA201800067B (en) Drospirenone-based contraceptive for a female patient affected with excess weight
SG11201703993RA (en) Imaging a body
PL3177723T3 (pl) Aptamery do zastosowania przeciwko chorobom związanym z autoprzeciwciałem
SG11201606247QA (en) Antimicrobial inserts for medical devices
GB201505032D0 (en) Orthotic insole
ZA201706201B (en) A soft high basis weight tissue
GB2539737B (en) Attachment for a wheelchair
GB201508300D0 (en) A prosthesis
AU366777S (en) Pessary
GB201508593D0 (en) A stent
GB201720992D0 (en) A medical use
GB2550099B (en) Airway stent
GB201517432D0 (en) Splint
GB201518078D0 (en) Model generation for drug determination
GB201407836D0 (en) A condom
PT3313408T (pt) Contracetivo à base de drospirenona para uma paciente do sexo feminino afetada com excesso de peso
PL3065678T3 (pl) Pessarium terapeutyczne
ZA201908327B (en) Weight optimization
GB2544276B (en) Height adjusting wheelchair
GB201521168D0 (en) A weight device
GB2532411B (en) A disposable female urinal
AU363888S (en) A weight
AU363854S (en) A weight
GB201702712D0 (en) Contraceptive compounds